BAJAJ HEALTHCARE
|
BAJAJ HEALTHCARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 6.33 | 13.59 | -5.19 | 23.02 | 25.87 |
| CEPS(Rs) | 14.51 | 22.43 | 4.82 | 29.26 | 32.26 |
| DPS(Rs) | 1.50 | 1.00 | 1.00 | 1.00 | 1.50 |
| Book NAV/Share(Rs) | 158.04 | 142.04 | 100.86 | 133.23 | 119.02 |
| Tax Rate(%) | 26.32 | 6.69 | 14.09 | 18.74 | 20.40 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 17.17 | 15.22 | 16.12 | 17.26 | 17.45 |
| EBIT Margin(%) | 8.39 | 13.65 | 2.76 | 14.84 | 15.07 |
| Pre Tax Margin(%) | 4.73 | 8.48 | -3.52 | 12.11 | 13.19 |
| PAT Margin (%) | 3.49 | 7.91 | -3.03 | 9.84 | 10.50 |
| Cash Profit Margin (%) | 8.00 | 13.06 | 2.81 | 12.50 | 13.09 |
| Performance Ratios | |||||
| ROA(%) | 2.47 | 5.51 | -1.74 | 7.84 | 11.45 |
| ROE(%) | 4.35 | 11.81 | -4.44 | 18.25 | 24.33 |
| ROCE(%) | 7.04 | 11.40 | 1.88 | 14.02 | 20.00 |
| Asset Turnover(x) | 0.71 | 0.70 | 0.58 | 0.80 | 1.09 |
| Sales/Fixed Asset(x) | 1.34 | 1.26 | 1.00 | 1.39 | 1.86 |
| Working Capital/Sales(x) | 2.36 | 2.51 | 194.46 | 9.67 | 8.92 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.74 | 0.79 | 1.00 | 0.72 | 0.54 |
| Receivable days | 145.02 | 145.27 | 144.33 | 107.01 | 76.07 |
| Inventory Days | 112.87 | 102.90 | 136.01 | 104.01 | 68.82 |
| Payable days | 124.08 | 120.59 | 124.77 | 90.43 | 78.13 |
| Valuation Parameters | |||||
| PER(x) | 45.77 | 49.42 | - | 13.24 | 13.16 |
| PCE(x) | 19.96 | 29.94 | 60.73 | 10.42 | 10.55 |
| Price/Book(x) | 1.83 | 4.73 | 2.90 | 2.29 | 2.86 |
| Yield(%) | 0.52 | 0.15 | 0.34 | 0.33 | 0.44 |
| EV/Net Sales(x) | 1.92 | 4.31 | 2.40 | 1.91 | 1.76 |
| EV/Core EBITDA(x) | 10.45 | 22.92 | 13.37 | 10.93 | 9.94 |
| EV/EBIT(x) | 22.85 | 31.56 | 86.93 | 12.89 | 11.65 |
| EV/CE(x) | 1.53 | 3.39 | 1.86 | 1.58 | 1.66 |
| M Cap / Sales | 1.60 | 3.91 | 1.71 | 1.30 | 1.38 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 12.61 | 14.61 | -26.69 | -5.01 | 3.49 |
| Core EBITDA Growth(%) | 9.86 | 19.95 | -24.81 | -5.86 | -16.18 |
| EBIT Growth(%) | -30.82 | 466.58 | -86.36 | -6.45 | -19.42 |
| PAT Growth(%) | -50.36 | 399.64 | -122.55 | -11.00 | -14.11 |
| EPS Growth(%) | -53.43 | 361.84 | -122.55 | -11.00 | -57.05 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.44 | 0.50 | 1.19 | 1.13 | 0.78 |
| Current Ratio(x) | 1.84 | 1.79 | 1.01 | 1.15 | 1.24 |
| Quick Ratio(x) | 1.14 | 1.20 | 0.65 | 0.67 | 0.74 |
| Interest Cover(x) | 2.30 | 2.64 | 0.44 | 5.42 | 8.02 |
| Total Debt/Mcap(x) | 0.24 | 0.10 | 0.41 | 0.49 | 0.27 |
Compare Financial Ratios of peers of BAJAJ HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAJAJ HEALTHCARE | ₹1,189.1 Cr | 4.7% | 4.4% | -22.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,476.0 Cr | -0.5% | -3% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,764.0 Cr | 1.6% | 9.3% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,423.0 Cr | 3.5% | 2.3% | 40.6% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | 1.6% | -3.2% | -11.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,005.0 Cr | 5.8% | 3.2% | -8.3% | Stock Analytics | |
BAJAJ HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAJAJ HEALTHCARE | 4.7% |
4.4% |
-22.9% |
| SENSEX | 0.7% |
-3.9% |
-8.9% |
You may also like the below Video Courses
